Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials

Radiotherapy and Oncology

Volumn 118, Issue 2, 2016, Pages 238-243

  Budach, Wilfried ^a   Bölke, Edwin ^a   Kammers, Kai ^b   Gerber, Peter Arne ^a   Orth, Klaus ^c   Gripp, Stephan ^a   Matuschek, Christiane ^a  

^a Department of Orthopedic Surgery   (Germany)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Medical Faculty   (Germany)

Author keywords

Head and neck cancer; Induction chemotherapy; Meta analysis; Radiotherapy; Squamous cell carcinoma of the head and neck; TPF

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; ANTINEOPLASTIC AGENT; TAXOID;

CANCER SURVIVAL; CHEMORADIOTHERAPY; CONFERENCE PAPER; EFFECT SIZE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INDUCTION CHEMOTHERAPY; LARYNX CARCINOMA; META ANALYSIS; MOUTH CARCINOMA; MULTIMODALITY CANCER THERAPY; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME; CARCINOMA, SQUAMOUS CELL; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; HEAD AND NECK NEOPLASMS; MALE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; DISEASE-FREE SURVIVAL; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; INDUCTION CHEMOTHERAPY; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TAXOIDS; TREATMENT OUTCOME;

EID: 84960290102     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2015.10.014     Document Type: Conference Paper

References (27)

1. M. Al-Sarraf, T.F. Pajak, V.A. Marcial, and et al. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG study Cancer 59 1987 259 265
2. J.B. Vermorken, E. Remenar, C. van Herpen, and et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 2007 1695 1704
3. J. Bernier, J.S. Cooper, T.F. Pajak, and et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) Head Neck 27 2005 843 850
4. K. Ang, R. Weber, E. Vokes, and et al. Radiation Therapy Oncology Group. Research plan 2002-2006. Head and Neck Cancer Committee Int J Radiat Oncol Biol Phys 51 2001 39 43
5. F. Alongi, M. Bignardi, I. Garassino, and et al. Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients Strahlenther Onkol 188 2012 49 55
6. R. Cotter, S. Blacksburg, T. Carpenter, and et al. Does response to induction chemotherapy (IC) predict locoregional control after concurrent chemoradiotherapy (CCRT) in locally advanced head and neck cancer (LAHNC)? Oral Oncol 50 2014 e27-8
7. P. Balermpas, C. Bauer, I. Fraunholz, and et al. Concomitant chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy as definitive, first line treatment of squamous cell carcinoma of the head and neck. A retrospective single center analysis Strahlenther Onkol 190 2014 256 262
8. R. Graf, B. Hildebrandt, W. Tilly, and et al. A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas BMC Cancer 6 2006 30
9. J.L. Lefebvre, Y. Pointreau, F. Rolland, and et al. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study J Clin Oncol 31 2013 853 859
10. M. Al-Sarraf, T.F. Pajak, R.W. Byhardt, and et al. Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24 Int J Radiat Oncol Biol Phys 37 1997 777 782
11. M.R. Posner, D.M. Hershock, C.R. Blajman, and et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 2007 1705 1715
12. J.P. Pignon, A. le Maitre, E. Maillard, and et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients Radiother Oncol 92 2009 4 14
13. P. Blanchard, J. Bourhis, B. Lacas, and et al. Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group J Clin Oncol 31 2013 2854 2860
14. R. Haddad, A. O'Neill, G. Rabinowits, and et al. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial Lancet Oncol 14 2013 257 264
15. R. Hitt, J.J. Grau, A. Lopez-Pousa, and et al. A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer Ann Oncol 25 2014 216 225
16. A. Paccagnella, M.G. Ghi, L. Loreggian, and et al. Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study Ann Oncol 21 2010 1515 1522
17. W. Cohen, T.G. Karrison, and M. Kocherginsky DeCIDE: a phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN) J Clin Oncol 30 2012 [abstr 5500]
18. Z. Takacsi-Nagy, E. Hitre, and E. Remenar Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: results of a randomized phase II study Strahlenther Onkol 2015
19. E.E. Cohen, T.G. Karrison, M. Kocherginsky, and et al. Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer J Clin Oncol 32 2014 2735 2743
20. M Ghi, A. Paccagnella, D Ferrari, P. Foa, M. Cossu Rocca, E. Verri, and et al. Concomitant CRT or cetuximab/RT vs induction docetaxel/cisplatin/5FU (TPF) followed by CRT or cetuximab/RT in patients with LASCCHN. A randomized phase III factorial study. Efficacy results (NCT01086826) J Clin Oncol 32 2014 [suppl; abstr 6004]
21. J.W. Chen, X.P. Zhang, J.K. Zheng, J.J. Su, M. Wu, and L.H. Xioa A randomized control trial of induction chemotherapy combined with concurrent chemoradiotherapy for patients with locally advanced head and neck squamous cell carcinoma J Chongqing Med Univ 36 2011 11103 11106
22. Collaboration TC, Green EJPHaS: Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011].
23. M Ghi, A. Paccagnella, D. Ferrari, P. Foa, MC Rocca, E. Verri, and et al. A phase II-III study comparing concomitant chemoradiotherapy (CRT) versus cetuximab/RT (CET/RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Efficacy results (NCT01086826) J Clin Oncol 31 2013 [suppl; abstr 6003]
24. M.K. Parmar, V. Torri, and L. Stewart Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 1998 2815 2834
25. Y. Pointreau, P. Garaud, S. Chapet, and et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation J Natl Cancer Inst 101 2009 498 506
26. L. Zhang, N. Jiang, Y. Shi, and et al. Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis Sci Rep 5 2015 10798
27. R. Hitt, J. Grau, A. Lopez-Pousa, A. Berrocal, C. Garcia Giron, A. Irigoyen, and et al. Final results of a randomized phase III trial comparing induction chemotherapy with cisplatin/5FU or docetaxel/cisplatin/5FU follow by chemoradiotherapy (CRT) versus CRT alone as first-line treatment od unresectable locally advanced head and neck cancer (LAHNC) Proc Am Soc Clin Oncol 27 2009 [abstr 15s]